A REVIEW OF HEMGENIX

Amount of qualified sufferers: CDEC talked over the uncertainty in the quantity of individuals with reasonably intense to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some people who're classified as having gentle or moderate illness may have a severe bleeding pheno